- Home
- CRNX vs ICUCW Comparison
CRNX vs ICUCW Comparison
Compare CRNX & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ICUCW
- Stock Information
- Founded
- CRNX 2008
- ICUCW N/A
- Country
- CRNX United States
- ICUCW United States
- Employees
- CRNX N/A
- ICUCW 19
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- CRNX Health Care
- ICUCW Health Care
- Exchange
- CRNX Nasdaq
- ICUCW Nasdaq
- Market Cap
- CRNX N/A
- ICUCW N/A
- IPO Year
- CRNX 2018
- ICUCW 2021
- Fundamental
- Price
- CRNX $30.68
- ICUCW $0.03
- Analyst Decision
- CRNX Strong Buy
- ICUCW
- Analyst Count
- CRNX 12
- ICUCW 0
- Target Price
- CRNX $73.36
- ICUCW N/A
- AVG Volume (30 Days)
- CRNX 841.7K
- ICUCW N/A
- Earning Date
- CRNX 05-08-2025
- ICUCW N/A
- Dividend Yield
- CRNX N/A
- ICUCW N/A
- EPS Growth
- CRNX N/A
- ICUCW N/A
- EPS
- CRNX N/A
- ICUCW N/A
- Revenue
- CRNX $760,000.00
- ICUCW N/A
- Revenue This Year
- CRNX $356.40
- ICUCW N/A
- Revenue Next Year
- CRNX $700.38
- ICUCW N/A
- P/E Ratio
- CRNX N/A
- ICUCW N/A
- Revenue Growth
- CRNX N/A
- ICUCW N/A
- 52 Week Low
- CRNX $24.10
- ICUCW N/A
- 52 Week High
- CRNX $62.53
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- CRNX 44.96
- ICUCW N/A
- Support Level
- CRNX $30.35
- ICUCW N/A
- Resistance Level
- CRNX $34.68
- ICUCW N/A
- Average True Range (ATR)
- CRNX 1.60
- ICUCW 0.00
- MACD
- CRNX 0.00
- ICUCW 0.00
- Stochastic Oscillator
- CRNX 7.62
- ICUCW 0.00
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.